KCNE5 ( KCNE1L ) Variants Are Novel Modulators of Brugada Syndrome and Idiopathic Ventricular Fibrillation

Latent Genetic Backgrounds and Molecular Pathogenesis in Drug-Induced Long-QT Syndrome

(2009) Hideki Itoh et al.   Circulation-Arrhythmia and Electrophysiology

NovelKCNE3mutation reduces repolarizing potassium current and associated with long QT syndrome

(2009) Seiko Ohno et al.   HUMAN MUTATION

A transient outward potassium current activator recapitulates the electrocardiographic manifestations of Brugada syndrome

(2008) K. Calloe et al.   CARDIOVASCULAR RESEARCH

Mutation Analysis of the Glycerol-3 Phosphate Dehydrogenase-1 Like (GPD1L) Gene in Japanese Patients With Brugada Syndrome

(2008) Takeru Makiyama et al.   CIRCULATION JOURNAL

Functional Effects of KCNE3 Mutation and Its Role in the Development of Brugada Syndrome

(2008) Eva Delpón et al.   Circulation-Arrhythmia and Electrophysiology

Gain of function in IKs secondary to a mutation in KCNE5 associated with atrial fibrillation

(2008) Lasse S. Ravn et al.   HEART RHYTHM

Gender Differences in Clinical Manifestations of Brugada Syndrome

(2008) Begoña Benito et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY